Phase
Condition
Severe Premenstrual Symptom
Mood Disorders
Bipolar Disorder
Treatment
Yaz
Placebo
Clinical Study ID
Ages 16-45 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
16-45 years of age
Diagnosis of BD (clinically euthymic) according to the DSM-5
Diagnosis of PMDD according to the DSM-5
Regular menstrual cycles
No contraindication to use oral contraceptives
Capable of consent for treatment
Exclusion
Exclusion Criteria:
Smoking and over the age of 35
Current or recent (last month) use of systemic estrogen or progesterone treatment
Severe reactions to hormone treatment
Pregnant or breastfeeding
Current substance use disorder
Oophorectomy or hysterectomy
Current unstable medical conditions
History of current or past breast cancer, pancreatitis, migraines or blood clottingdisorders.
Study Design
Connect with a study center
St Joseph's Healthcare Hamilton
Hamilton, Ontario L8N 3K7
CanadaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.